Thymulin
- 1 lab in 1 country
- Funder: National Cancer Institute
- Animals1
Outcomes
4Tumor sensitivity to anti-PD-L1 therapy
upin animals1
1 study
Tumor sensitivity to anti-PD-L1 therapy
upin animals1
Thymulin increases tumor sensitivity to anti-PD-L1 therapy.
“Furthermore, thymulin enhances antitumor T-cell immunity, improves tumor control and survival, and sensitizes tumors to anti-PD-L1 therapy in an age-dependent manner.”
Animalsage-dependent effecttumor
Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy
Nature communications21 Jul 2026
Survival
upin animals1
1 study
Survival
upin animals1
Thymulin increases survival.
“Furthermore, thymulin enhances antitumor T-cell immunity, improves tumor control and survival”
Animalscancer
Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy
Nature communications21 Jul 2026
Antitumor T-cell immunity
upin animals1
1 study
Antitumor T-cell immunity
upin animals1
Thymulin increases antitumor T-cell immunity.
“Furthermore, thymulin enhances antitumor T-cell immunity”
Animals
Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy
Nature communications21 Jul 2026
Pro-inflammatory cytokine production
downin animals1
1 study
Pro-inflammatory cytokine production
downin animals1
Thymulin decreases pro-inflammatory cytokine production.
“as a mediator that suppresses pro-inflammatory cytokine production by inhibiting NF-κB signaling.”
Animalsthrough inhibition of NF-κB signalingmyeloid cell
Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy
Nature communications21 Jul 2026